Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Piddock

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|September 25, 2019
High <i>in vitro</i> susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical <i>Neisseria gonorrhoeae</i> isolates from Thailand (2018) and South Africa (2015-2017)Susanne Jacobsson, Ranmini Kularatne, Rossaphorn Kittiyaowamarn, et al.
BMJ Open Science|January 20, 2022
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocolElda Righi, Luigia Scudeller, Margherita Chiamenti, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|September 25, 2019
High <i>in vitro</i> susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical <i>Neisseria gonorrhoeae</i> isolates from Thailand (2018) and South Africa (2015-2017)Susanne Jacobsson, Ranmini Kularatne, Rossaphorn Kittiyaowamarn, et al.
BMJ Open Science|January 20, 2022
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocolElda Righi, Luigia Scudeller, Margherita Chiamenti, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Pageof 2